Načítá se...
mTORC2 controls cancer cell survival by modulating gluconeogenesis
For rapid tumor growth, cancer cells often reprogram the cellular metabolic processes to obtain enhanced anabolic precursors and energy. The molecular changes of such metabolic rewiring are far from established. Here we explored the role of mTOR (mechanistic target of rapamycin), which serves as a k...
Uloženo v:
| Vydáno v: | Cell Death Discov |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4979518/ https://ncbi.nlm.nih.gov/pubmed/27551450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddiscovery.2015.16 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|